西隴科學(002584.SZ):目前有76%的雙氧水產能分佈在華東及華中地區
格隆匯5月8日丨有投資者在投資者互動平台向西隴科學(002584.SZ)提問,“請問貴司生產的雙氧水市場佔比如何?可否填補目前因西魯化工爆炸造成短期的市場緊缺?別外,網傳德國考慮限制對華出口半導體試劑,請問貴司是否有相關試劑可以做到國產替代進口?”
西隴科學回複稱,雙氧水由於化學性質不穩定、易爆的特殊性,具有一定的銷售半徑(300~500km),行業產能分散,產能集中度較低,競爭較為激烈。目前有76%的雙氧水產能分佈在華東及華中地區。公司生產基地主要位於華南。 公司自產自研的高效液相色譜淋洗液(梯度級)甲醇、梯度級乙腈、光譜級溴化鉀等產品達到了國內外同行業標準,且同等品質下價格更有競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.